| |
| |
|
| Insider
Information: |
Roberts William |
| Relationship: |
VP Reg Dev & Med Safety |
| City: |
Tarrytown |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
16,644 |
|
|
Indirect Shares
|
55,634 |
|
|
| Direct
Value |
$15,955,604 |
|
|
|
Indirect Value
|
$53,332,978 |
|
|
| Total
Shares |
72,278 |
|
|
| Total
Value |
$69,288,582 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Regeneron Pharmaceuticals Inc |
REGN |
VP Reg Dev & Med Safety |
2013-10-02 |
16,644 |
2013-10-02 |
55,634 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| REGN |
Regeneron Pharmaceuticals... |
VP Reg Dev & Med Safety |
• – – |
2013-10-02 |
5 |
GA |
$0.00 |
$0 |
I/I |
18,399 |
31,846 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
VP Reg Dev & Med Safety |
• – – |
2013-09-19 |
4 |
GD |
$0.00 |
$0 |
D/D |
4,000 |
16,644 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
VP Reg Dev & Med Safety |
• – – |
2013-09-18 |
4 |
AS |
$304.00 |
$4,560,000 |
D/D |
(15,000) |
20,644 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
VP Reg Dev & Med Safety |
• – – |
2013-09-18 |
4 |
OE |
$16.80 |
$252,000 |
D/D |
15,000 |
35,644 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
VP Reg Dev & Med Safety |
• – – |
2013-06-13 |
4 |
GA |
$0.00 |
$0 |
D/D |
4,000 |
20,644 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
VP Reg Dev & Med Safety |
• – – |
2013-06-13 |
4 |
GD |
$0.00 |
$0 |
I/I |
4,000 |
13,447 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
VP Regulat Dev & Med Safety |
• – – |
2012-11-30 |
4 |
S |
$177.43 |
$2,078,975 |
I/I |
(11,500) |
0 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
VP Regulat Dev & Med Safety |
• – – |
2012-11-27 |
4 |
GD |
$0.00 |
$0 |
I/I |
11,500 |
17,447 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
VP Regulat Dev & Med Safety |
• – – |
2012-11-27 |
4 |
GA |
$0.00 |
$0 |
I/I |
11,500 |
11,500 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
VP Regulat Dev & Med Safety |
• – – |
2012-11-05 |
4 |
GA |
$0.00 |
$0 |
I/I |
26,000 |
45,947 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
VP Regulat Dev & Med Safety |
• – – |
2012-11-05 |
4 |
GD |
$0.00 |
$0 |
D/D |
26,000 |
16,644 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
VP Regulat Dev & Med Safety |
• – – |
2012-09-04 |
4 |
GA |
$0.00 |
$0 |
I/I |
19,947 |
19,947 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
VP Regulatory Development and |
• – – |
2012-08-24 |
4 |
GD |
$0.00 |
$0 |
D/D |
3,500 |
42,644 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
VP Regulatory Development and |
• – – |
2012-08-23 |
4 |
AS |
$144.00 |
$2,160,000 |
D/D |
(15,000) |
46,144 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
VP Regulatory Development and |
• – – |
2012-01-11 |
4 |
AS |
$73.99 |
$1,681,882 |
D/D |
(22,148) |
61,144 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
VP Regulatory Development and |
• – – |
2012-01-10 |
4 |
AS |
$74.35 |
$708,407 |
D/D |
(9,528) |
61,144 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
VP Regulatory Development and |
• – – |
2012-01-10 |
4 |
OE |
$20.32 |
$1,267,200 |
D/D |
60,000 |
97,182 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
VP Regulatory Development and |
• – – |
2012-01-10 |
4 |
D |
$73.92 |
$2,093,710 |
D/D |
(28,324) |
83,292 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
VP Regulatory Development and |
• – – |
2011-12-07 |
4 |
GD |
$0.00 |
$0 |
I/I |
3,647 |
0 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
VP Regulatory Development and |
• – – |
2011-12-07 |
4 |
GD |
$0.00 |
$0 |
D/D |
5,812 |
61,144 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
VP Regulatory Development and |
• – – |
2011-09-07 |
4 |
AS |
$67.48 |
$453,324 |
D/D |
(6,503) |
66,956 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
VP Regulatory Development and |
• – – |
2011-09-06 |
4 |
AS |
$62.76 |
$1,092,649 |
D/D |
(16,463) |
73,459 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
VP Regulatory Development and |
• – – |
2011-09-06 |
4 |
OE |
$11.64 |
$349,200 |
D/D |
30,000 |
75,144 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
VP Regulatory Development and |
• – – |
2011-09-06 |
4 |
D |
$65.76 |
$462,556 |
D/D |
(7,034) |
73,459 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
VP Regulatory Development and |
• – – |
2011-07-14 |
4 |
AS |
$56.43 |
$6,237 |
I/I |
(110) |
3,647 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
